Helix Acquisition Corp - MLTX
-
Commons
$25.88
-7.80%MLTX Vol: 385.6K
SPAC Stats
Market Cap: 0.0
Average Volume: 0.0
52W Range: $0.00 - $0.00
Weekly %: +0.00%
Monthly %: +0.00%
Inst Owners: 0
Info
🎯Price Targets
Rating
Analyst Firm
Price Target
07/21/22
Buy - $28.0
🕵Stocktwit Mentions
STCKPRO posted at 2023-06-21T10:36:35Z
$MLTX NEW ARTICLE : MoonLake Immunotherapeutics (MLTX) Receives a Buy from H.C. Wainwright https://www.stck.pro/news/MLTX/53713456/
mrshort posted at 2023-06-19T14:06:16Z
$MLTX Estimated S.I as on 6/16/23 78.42 Percent Please complete information please join me via stocktwits.com/mrshort, for stock alerts, news, chat rooms, squeeze ranking watchlist. We are consistency hitting profit with our trading strategy. MLTX has Institutional ownership of 17.67% and inside ownership of 14.20% Analyst rating 4.10 and Long Term Debt/ Capital - Our members daily updated information of highly shorted stock, squeeze ranking, access to Chat rooms, IPO analysis, Daily watchlist, Market Watchlist.Catalyst.
mrshort posted at 2023-06-16T12:22:56Z
$MLTX Estimated S.I as on 6/15/23 77.89 Percent Please complete information please join me via stocktwits.com/mrshort, for stock alerts, news, chat rooms, squeeze ranking watchlist. We are consistency hitting profit with our trading strategy. MLTX has Institutional ownership of 17.67% and inside ownership of 14.20% Analyst rating 4.10 and Long Term Debt/ Capital - Our members daily updated information of highly shorted stock, squeeze ranking, access to Chat rooms, IPO analysis, Daily watchlist, Market Watchlist.Catalyst.
MarketBeat posted at 2023-06-15T11:35:19Z
MoonLake Immunotherapeutics initiated by Barclays PLC at equal weight. www.marketbeat.com/stocks/NASDAQ/MLTX/price-target/ $MLTX
Quantisnow posted at 2023-06-15T11:32:15Z
$MLTX 📋 Barclays initiated coverage on MoonLake Immunotherapeutics with a new price target https://quantisnow.com/i/4644530?utm_source=stocktwits 45 seconds delayed.
STCKPRO posted at 2023-06-15T09:17:23Z
$MLTX NEW ARTICLE : Analysts Have Conflicting Sentiments on These Healthcare Companies: Nurix Therapeutics (NRIX), MoonLake Immunotherapeutics (MLTX) and Zoetis (ZTS) https://www.stck.pro/news/MLTX/53130203/
mrshort posted at 2023-06-15T02:13:50Z
$MLTX Estimated S.I as on 6/14/23 77.62 Percent Please complete information please join me via stocktwits.com/mrshort, for stock alerts, news, chat rooms, squeeze ranking watchlist. We are consistency hitting profit with our trading strategy. MLTX has Institutional ownership of 17.67% and inside ownership of 14.20% Analyst rating 4.10 and Long Term Debt/ Capital - Our members daily updated information of highly shorted stock, squeeze ranking, access to Chat rooms, IPO analysis, Daily watchlist, Market Watchlist.Catalyst.
STCKPRO posted at 2023-06-13T22:48:16Z
$MLTX NEW ARTICLE : BTIG Sticks to Its Buy Rating for MoonLake Immunotherapeutics (MLTX) https://www.stck.pro/news/MLTX/52995057/
shortablestocks posted at 2023-06-13T11:59:05Z
$MLTX is short sale restricted for 2023-06-13. https://www.shortablestocks.com/?MLTX
StockAutomatePro posted at 2023-06-13T01:20:41Z
$MLTX Chart analysis points towards a downward stock trajectory. We alerted the SELL signal at $29.75 and we were able to close this one with profit at $26.37 😎 See more details at StockAutomate.com
Quantisnow posted at 2023-06-13T01:12:45Z
$MLTX 📜 SEC Form 4 filed by Bvf Partners L P/Il https://quantisnow.com/i/4632491?utm_source=stocktwits 45 seconds delayed.
Quantisnow posted at 2023-06-12T21:21:04Z
$MLTX Several insights in the last few minutes: 1. 📜 SEC Form 4 filed by Moukheibir Catherine https://quantisnow.com/i/4631522?utm_source=stocktwits 2. 📜 SEC Form 4 filed by Loy Spike https://quantisnow.com/i/4631547?utm_source=stocktwits 3. 📜 SEC Form 4 filed by Xavier Ramnik https://quantisnow.com/i/4631564?utm_source=stocktwits 4. 📜 SEC Form 4 filed by Sturge Simon https://quantisnow.com/i/4631587?utm_source=stocktwits #healthcare
fla posted at 2023-06-12T20:58:57Z
$MLTX [15s. delayed] filed SEC form 4: Director Sturge Simon: Transacted Derivative Securities on 2023-06-08. https://s.flashalert.me/bWUqrZ
fla posted at 2023-06-12T20:56:25Z
$MLTX [15s. delayed] filed SEC form 4: Director Xavier Ramnik: Transacted Derivative Securities on 2023-06-08. https://s.flashalert.me/M0Y2S
fla posted at 2023-06-12T20:53:39Z
$MLTX [15s. delayed] filed SEC form 4: Director Loy Spike: Transacted Derivative Securities on 2023-06-08. https://s.flashalert.me/x8AQu
fla posted at 2023-06-12T20:50:14Z
$MLTX [15s. delayed] filed SEC form 4: Director Moukheibir Catherine: Transacted Derivative Securities on 2023-06-08. https://s.flashalert.me/tN5IX
Quantisnow posted at 2023-06-12T20:48:26Z
$MLTX 📜 SEC Form 4 filed by Phillips Andrew John https://quantisnow.com/i/4631503?utm_source=stocktwits 45 seconds delayed.
fla posted at 2023-06-12T20:48:11Z
$MLTX [15s. delayed] filed SEC form 4: Director Phillips Andrew John: Transacted Derivative Securities on 2023-06-08. https://s.flashalert.me/y0W6D
intratio posted at 2023-06-11T03:31:24Z
https://www.intratio.com/stock-forecast/MLTX MoonLake Immunotherapeutics Our AI has detected that the price action of this stock has an extremely bleak prognosis for the near future with a very negative long-term outlook $MLTX
intratio posted at 2023-06-10T12:25:56Z
$MLTX https://www.intratio.com/stock-forecast/MLTX Our trained model lets us believe this stock s value will decrease during the next few days and will have a very negative trend in the upcoming months
intratio posted at 2023-06-08T12:33:07Z
$MLTX MoonLake Immunotherapeutics Our advanced model concludes that the value of this company plainly has a bad short-term setup and has really poor long-term fundamentals
ChartMill posted at 2023-06-08T10:21:00Z
$MLTX, $IMTX and $SWAV are showing a squeeze play pattern today. They could be ready for breakout. https://www.chartmill.com/stock/stock-screener?sid=12&f=sqds,v1_50b300,sl_ti_105_X,exch_us&v=3&timeframe=DAILY&type=CANDLES&months=0.05&width=400&cl=F&o1=0&o2=57&op1=14&op2=20,1.5,10&utm_source=stocktwits&utm_medium=screener&utm_content=Stock_Screener:_Momentum_Squeeze_Play_Setups&utm_campaign=social_tracking
Last10K posted at 2023-06-07T20:53:18Z
$MLTX just filed with the SEC a Vote of Security Holders https://last10k.com/sec-filings/mltx/0001213900-23-047184.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=mltx
EarningsInsider posted at 2023-06-07T20:42:12Z
MoonLake Immunotherapeutics Files SEC Form 8-K $MLTX https://www.marketbeat.com/stocks/NASDAQ/MLTX/sec-filings/
risenhoover posted at 2023-06-07T20:32:37Z
$MLTX / MoonLake Immunotherapeutics - files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 7, 2023 MoonLake Immunothera https://fintel.io/sf/us/mltx?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing
Quantisnow posted at 2023-06-07T20:32:23Z
$MLTX 📜 MoonLake Immunotherapeutics filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders https://quantisnow.com/i/4615769?utm_source=stocktwits 45 seconds delayed.
fla posted at 2023-06-07T20:31:58Z
$MLTX [15s. delayed] filed form 8-K on June 07, 16:31:07 https://s.flashalert.me/rdS8o6
mrshort posted at 2023-06-07T01:32:12Z
$MLTX Estimated S.I as on 6/6/23 89.27 Percent Please complete information please join me via stocktwits.com/mrshort, for stock alerts, news, chat rooms, squeeze ranking watchlist. We are consistency hitting profit with our trading stratergy. MLTX has Institutional ownership of 17.58% and inside ownership of 14.21% Analyst rating 4.10 and Long Term Debt/ Capital - Our members daily updated information of highly shorted stock, squeeze ranking, access to Chat rooms, IPO analysis, Daily watchlist, Market Watchlist.Catalyst.
BidaskBot posted at 2023-06-06T20:30:15Z
MoonLakeImmunotherapeutics $MLTX BidaskScore is Upgraded to StronglyBought https://bidaskclub.com/news/company/2023-06-05/MLTX
intratio posted at 2023-06-06T08:05:02Z
The engine judges that this company s stock price will drop in the coming days and foretells a grimly dismal future $MLTX